 SAN DIEGO , Sept. 6, 2022 PRNewswire -- Aethlon Medical, Inc. Nasdaq: AEMD, a medical therapeutic company focused on developing products to diagnose and treat cancer and life-threatening infectious diseases, today announced that it will be presenting at two investor conferences in September. 